LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-20
Case ID: NM_002439.5_c.1327G_A_20261120_225324
Framework: ACMG/AMP 2015
Variant classification summary

NM_002439.5:c.1327G>A

MSH3  · NP_002430.3:p.(Ala443Thr)  · NM_002439.5
GRCh37: chr5:79974899 G>A  ·  GRCh38: chr5:80679080 G>A
Gene: MSH3 Transcript: NM_002439.5
Final call
VUS
PM2 moderate BP4 supporting
All criteria require review: For research and educational purposes only.
Gene
MSH3
Transcript
NM_002439.5
Protein
NP_002430.3:p.(Ala443Thr)
gnomAD AF
1.858934161509157e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 moderate: gnomAD v4.1 reports an allele frequency of 1.85893e-06 with no homozygotes.
2
BP4 supporting: REVEL 0.222 is below the generic missense threshold of 0.29.
Final determination: Under the generic ACMG/AMP 2015 fallback, one Moderate pathogenic criterion and one Supporting benign criterion satisfy neither a pathogenic nor a benign combination rule, so the call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: no previously established pathogenic MSH3 variant with the same p.Ala443Thr amino-acid change is documented.
clinvar
PS2 Not assessed Not assessed: no documented proband disease, family-history status, or confirmed maternity and paternity is available for this variant.
PS3 Not assessed Not assessed: no variant-specific functional assay or damaging-effect result was identified for MSH3 p.Ala443Thr.
oncokb PMID:25394175 PMID:26991699
PS4 Not met Not met: no exact-variant affected-case/control comparison or OR >5.0 with a confidence interval excluding 1.0 was reported.
PMID:25394175 PMID:26991699 gnomad_v4
PM1 Not met Not met: Cancer Hotspots found no statistically significant MSH3 A443 hotspot, and no critical-domain annotation covers residue 443.
hotspots
PM2 Met Met at Moderate: gnomAD v4.1 total AF is 1.85893e-06, below the PM2 cutoff of 0.0001, with 0 homozygotes.
gnomad_v2 gnomad_v4
PM3 Not assessed Not assessed: no affected-proband observation or parental/offspring phase testing establishes this variant in trans with a pathogenic variant.
clinvar
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: zero same-residue comparator candidates were identified for MSH3 Ala443, so no different pathogenic missense change supports PM5.
pm5_candidates
PM6 Not assessed Not assessed: no documented assumed de novo occurrence is available, regardless of whether parental maternity or paternity was confirmed.
PP1 Not assessed Not assessed: no affected relatives, matching genotypes, phenotype concordance, or informative meioses are documented for segregation analysis.
PP2 Not assessed Not assessed: gnomAD v4.1 AF is 1.85893e-06, but gene-wide evidence for low benign missense variation and a common missense mechanism is missing.
gnomad_v4
PP3 Not met Not met: REVEL 0.222 is below the PP3 supporting cutoff of >=0.644 for this missense variant.
revel
PP4 Not assessed Not assessed: no patient phenotype or family-history details were available to evaluate high specificity for a single-gene disease.
PP5 Not met Not met: ClinVar has no exact-variant expert-panel Pathogenic or Likely pathogenic classification, only single-submitter assertions.
clinvar PMID:25394175
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 6.8e-07, far below the BA1 threshold of 0.05.
gnomad_v4
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 6.8e-07 versus the generic BS1 threshold of 0.01.
gnomad_v4
BS2 Not met Not met: gnomAD v4.1 reports 0 homozygotes among 3 observed alleles and 1,613,828 total alleles.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no validated variant-specific assay demonstrated that MSH3 p.Ala443Thr has no damaging effect on protein function or splicing.
oncokb PMID:25394175 PMID:26991699
BS4 Not assessed Not assessed: no affected relatives with documented variant-negative testing are available to demonstrate lack of segregation.
BP1 Not assessed Not assessed: the available registered evidence does not establish that MSH3 disease is caused primarily by truncating variants.
BP2 Not assessed Not assessed: the exact variant record contains no phase or second-variant data demonstrating trans occurrence in a dominant disorder or cis occurrence with a pathogenic variant.
clinvar
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Met Met: REVEL 0.222 is below the BP4 supporting cutoff of <=0.29 for this missense variant.
revel
BP5 Not assessed Not assessed: no case evidence showed this variant alongside an alternate molecular basis for the patient's disease.
clinvar
BP6 Not met Not met: the only exact-variant Likely benign ClinVar assertion is single-submitter, with no expert-panel benign classification.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.